81 FR 52908 - Importer of Controlled Substances Registration
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 81, Issue 154 (August 10, 2016)
Drug Enforcement Administration
Federal Register Volume 81, Issue 154 (August 10, 2016)
| Page Range | 52908-52908 | |
| FR Document | 2016-18922 |
[Federal Register Volume 81, Number 154 (Wednesday, August 10, 2016)] [Notices] [Page 52908] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-18922] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Registration ACTION: Notice of registration. ----------------------------------------------------------------------- SUMMARY: Registrants listed below have applied for and been granted registration by-the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances. SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as an importer of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. ------------------------------------------------------------------------ Company FR Docket Published ------------------------------------------------------------------------ Mylan Pharmaceuticals, Inc... 80 FR 75691.... December 3, 2015. Hospira...................... 81 FR 1208..... January 11, 2016. Cambrex Charles City......... 81 FR 14892.... March 18, 2016. Pharmacore................... 81 FR 15565.... March 23, 2016. Mallinckrodt LLC............. 81 FR 15566.... March 23, 2016. Meda Pharmaceuticals, Inc.... 81 FR 15560.... March 23, 2016. Stepan Company............... 81 FR 20417.... April 7, 2016 ------------------------------------------------------------------------ The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed persons. Dated: August 2, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016-18922 Filed 8-9-16; 8:45 am] BILLING CODE 4410-09-P
![52908 Federal Register / Vol. 81, No. 154 / Wednesday, August 10, 2016 / Notices
replace the volume of articles Commission should grant such By order of the Commission.
potentially subject to the recommended treatment. See 19 CFR 201.6. Documents Issued: August 4, 2016.
orders within a commercially for which confidential treatment by the Lisa R. Barton,
reasonable time; and Commission is properly sought will be Secretary to the Commission.
(v) explain how the recommended treated accordingly. All information, [FR Doc. 2016–18904 Filed 8–9–16; 8:45 am]
orders would impact consumers in the including confidential business BILLING CODE 7020–02–P
United States. information and documents for which
Written submissions must be filed no confidential treatment is properly
later than by close of business on sought, submitted to the Commission for
September 6, 2016. purposes of this Investigation may be DEPARTMENT OF JUSTICE
Persons filing written submissions disclosed to and used: (i) By the
must file the original document Commission, its employees and Offices, Drug Enforcement Administration
electronically on or before the deadlines and contract personnel (a) for [Docket No. DEA–392]
stated above and submit 8 true paper developing or maintaining the records
copies to the Office of the Secretary by of this or a related proceeding, or (b) in Importer of Controlled Substances
noon the next day pursuant to internal investigations, audits, reviews, Registration
Commission Rule 210.4(f), 19 CFR and evaluations relating to the
210.4(f). Submissions should refer to the programs, personnel, and operations of ACTION: Notice of registration.
investigation number (‘‘Inv. No. 947’’) in the Commission including under 5
a prominent place on the cover page U.S.C. Appendix 3; or (ii) by U.S. SUMMARY: Registrants listed below have
and/or the first page. (See Handbook for government employees and contract applied for and been granted
Electronic Filing Procedures, http:// personnel, solely for cybersecurity registration by-the Drug Enforcement
www.usitc.gov/secretary/fed_reg_ purposes. All contract personnel will Administration (DEA) as importers of
notices/rules/handbook_on_electronic_ sign appropriate nondisclosure various classes of schedule I or II
filing.pdf). Persons with questions agreements. All non-confidential controlled substances.
regarding filing should contact the written submissions will be available for SUPPLEMENTARY INFORMATION: The
Secretary, (202) 205–2000. public inspection at the Office of the companies listed below applied to be
Any person desiring to submit a Secretary and on EDIS. registered as an importer of various
document to the Commission in This action is taken under the basic classes of controlled substances.
confidence must request confidential authority of section 337 of the Tariff Act Information on previously published
treatment. All such requests should be of 1930, as amended (19 U.S.C. 1337), notices is listed in the table below. No
directed to the Secretary to the and part 210 of the Commission’s Rules comments or objections were submitted
Commission and must include a full of Practice and Procedure (19 CFR part and no requests for hearing were
statement of the reasons why the 210). submitted for these notices.
Company FR Docket Published
Mylan Pharmaceuticals, Inc. ................................................... 80 FR 75691 .......................................................................... December 3, 2015.
Hospira .................................................................................... 81 FR 1208 ............................................................................ January 11, 2016.
Cambrex Charles City ............................................................ 81 FR 14892 .......................................................................... March 18, 2016.
Pharmacore ............................................................................ 81 FR 15565 .......................................................................... March 23, 2016.
Mallinckrodt LLC ..................................................................... 81 FR 15566 .......................................................................... March 23, 2016.
Meda Pharmaceuticals, Inc. ................................................... 81 FR 15560 .......................................................................... March 23, 2016.
Stepan Company .................................................................... 81 FR 20417 .......................................................................... April 7, 2016
The DEA has considered the factors in with 21 CFR 1301.34, the DEA has SUMMARY: Registrants listed below have
21 U.S.C. 823, 952(a) and 958(a) and granted a registration as an importer for applied for and been granted
determined that the registration of the schedule I or II controlled substances to registration by-the Drug Enforcement
listed registrants to import the the above listed persons. Administration (DEA) as bulk
applicable basic classes of schedule I or Dated: August 2, 2016. manufacturers of various classes of
II controlled substances is consistent Louis J. Milione, controlled substances.
with the public interest and with United Deputy Assistant Administrator.
States obligations under international SUPPLEMENTARY INFORMATION: The
[FR Doc. 2016–18922 Filed 8–9–16; 8:45 am] companies listed below applied to be
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
BILLING CODE 4410–09–P registered as manufacturers of various
investigated each company’s basic classes of controlled substances.
maintenance of effective controls Information on previously published
DEPARTMENT OF JUSTICE
against diversion by inspecting and notices is listed in the table below. No
testing each company’s physical Drug Enforcement Administration comments or objections were submitted
security systems, verifying each for these notices.
[Docket No. DEA–392]
mstockstill on DSK3G9T082PROD with NOTICES
company’s compliance with state and
local laws, and reviewing each Bulk Manufacturer of Controlled
company’s background and history. Substances Registration
Therefore, pursuant to 21 U.S.C.
ACTION: Notice of registration.
952(a) and 958(a), and in accordance
VerDate Sep<11>2014 17:34 Aug 09, 2016 Jkt 238001 PO 00000 Frm 00099 Fmt 4703 Sfmt 4703 E:\FR\FM\10AUN1.SGM 10AUN1](https://thefederalregister.org/doc/81_FR_53062/page/1.svg)
Document Created: 2016-08-10 01:59:33
Document Modified: 2016-08-10 01:59:33
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of registration. | |
| FR Citation | 81 FR 52908 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR